ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

The Combination of R848 with Sorafenib Enhances Antitumor Effects by Reprogramming the Tumor Immune Microenvironment and Facilitating Vascular Normalization in Hepatocellular Carcinoma.

Yuchao He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.